Epirus OTC Stock Market Value

EPRSQ -  USA Stock  

USD 0.0001  0.00  0.00%

Epirus Biopharm's market value is the price at which a share of Epirus Biopharm stock trades on a public exchange. It measures the collective expectations of Epirus Biopharm investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Epirus Biopharm and determine expected loss or profit from investing in Epirus Biopharm over a given investment horizon. Continue to Epirus Biopharm Hype Analysis, Epirus Biopharm Correlation, Epirus Biopharm Valuation, Epirus Biopharm Volatility, as well as analyze Epirus Biopharm Alpha and Beta and Epirus Biopharm Performance.

The market value of Epirus Biopharm is measured differently than its book value, which is the value of Epirus that is recorded on the company's balance sheet. Investors also form their own opinion of Epirus Biopharm's value that differs from its market value or its book value, called intrinsic value, which is Epirus Biopharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Epirus Biopharm's market value can be influenced by many factors that don't directly affect Epirus Biopharm underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Epirus Biopharm's value and its price as these two are different measures arrived at by different means. Investors typically determine Epirus Biopharm value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Epirus Biopharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Epirus Biopharm 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Epirus Biopharm's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Epirus Biopharm.
No Change 0.00  0.0 
In 2 months and 1 day
If you would invest  0.00  in Epirus Biopharm on August 22, 2021 and sell it all today you would earn a total of 0.00 from holding Epirus Biopharm or generate 0.0% return on investment in Epirus Biopharm over 60 days. Epirus Biopharm is related to or competes with Wuxi Biologics, Ginkgo Bioworks, Csl, Biontech, Csl, Moderna, and Regeneron Pharmaceuticals. EPIRUS Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and commercializes biosimilar ther...

Epirus Biopharm Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Epirus Biopharm's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Epirus Biopharm upside and downside potential and time the market with a certain degree of confidence.

Epirus Biopharm Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Epirus Biopharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Epirus Biopharm's standard deviation. In reality, there are many statistical measures that can use Epirus Biopharm historical prices to predict the future Epirus Biopharm's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Epirus Biopharm's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Epirus Biopharm in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
Band Projection (param)
LowerMiddle BandUpper
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Epirus Biopharm. Your research has to be compared to or analyzed against Epirus Biopharm's peers to derive any actionable benefits. When done correctly, Epirus Biopharm's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Epirus Biopharm.

Epirus Biopharm Backtested Returns

Epirus Biopharm secures Sharpe Ratio (or Efficiency) of -0.002, which denotes the company had -0.002% of return per unit of risk over the last 3 months. Macroaxis standpoint towards predicting the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Epirus Biopharm exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Epirus Biopharm coefficient of variation of (34,107), and Mean Deviation of 10.15 to check the risk estimate we provide.
The firm shows a Beta (market volatility) of -0.5158, which means possible diversification benefits within a given portfolio. Let's try to break down what Epirus's beta means in this case. As returns on the market increase, returns on owning Epirus Biopharm are expected to decrease at a much lower rate. During the bear market, Epirus Biopharm is likely to outperform the market. Even though it is essential to pay attention to Epirus Biopharm historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards predicting any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Epirus Biopharm exposes twenty-one different technical indicators, which can help you to evaluate its performance. Epirus Biopharm has an expected return of -0.0434%. Please be advised to confirm Epirus Biopharm semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if Epirus Biopharm performance from the past will be repeated at some point in the near future.
AdviceVolatility TrendExposureCorrelations



Average predictability

Epirus Biopharm has average predictability. Overlapping area represents the amount of predictability between Epirus Biopharm time series from 22nd of August 2021 to 21st of September 2021 and 21st of September 2021 to 21st of October 2021. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Epirus Biopharm price movement. The serial correlation of 0.47 indicates that about 47.0% of current Epirus Biopharm price fluctuation can be explain by its past prices.
Correlation Coefficient0.47
Spearman Rank Test0.59
Residual Average0.0
Price Variance0.0

Epirus Biopharm lagged returns against current returns

Autocorrelation, which is Epirus Biopharm otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Epirus Biopharm's otc stock expected returns. We can calculate the autocorrelation of Epirus Biopharm returns to help us make a trade decision. For example, suppose you find that Epirus Biopharm otc stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 

Epirus Biopharm regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Epirus Biopharm otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Epirus Biopharm otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Epirus Biopharm otc stock over time.
 Current vs Lagged Prices 

Epirus Biopharm Lagged Returns

When evaluating Epirus Biopharm's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Epirus Biopharm otc stock have on its future price. Epirus Biopharm autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Epirus Biopharm autocorrelation shows the relationship between Epirus Biopharm otc stock current value and its past values and can show if there is a momentum factor associated with investing in Epirus Biopharm.
 Regressed Prices 

Epirus Biopharm Investors Sentiment

The influence of Epirus Biopharm's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Epirus. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - EPRSQ

Epirus Biopharm Investor Sentiment

Macroaxis portfolio users are insensible in their opinion about investing in Epirus Biopharm. What is your opinion about investing in Epirus Biopharm? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Trading with Epirus Biopharm

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Epirus Biopharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Epirus Biopharm will appreciate offsetting losses from the drop in the long position's value.

Epirus Biopharm Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Epirus Biopharm and Wuxi Biologics Cayman. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Epirus Biopharm Hype Analysis, Epirus Biopharm Correlation, Epirus Biopharm Valuation, Epirus Biopharm Volatility, as well as analyze Epirus Biopharm Alpha and Beta and Epirus Biopharm Performance. Note that the Epirus Biopharm information on this page should be used as a complementary analysis to other Epirus Biopharm's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Epirus OTC Stock analysis

When running Epirus Biopharm price analysis, check to measure Epirus Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epirus Biopharm is operating at the current time. Most of Epirus Biopharm's value examination focuses on studying past and present price action to predict the probability of Epirus Biopharm's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Epirus Biopharm's price. Additionally, you may evaluate how the addition of Epirus Biopharm to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Epirus Biopharm technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Epirus Biopharm technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Epirus Biopharm trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...